PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: DN Venture Partners

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Walter Reed Army Institute of Research and Siam Life Science Ltd Develop New Gold Standard for Pharmacological and Toxicological Test Systems - Siam Life Science Ltd (SLS) secures exclusive License for unique Liver Cell Line from Premier U.S. Research Organization, Walter Reed Army Institute of Research (WRI) - Siam-Lifescience.com
Walter Reed Army Institute of Research and Siam Life Science Ltd Develop New Gold Standard for Pharmacological and Toxicological Test Systems

 

NewswireToday - /newswire/ - Bangkok, Thailand, 2008/05/21 - Siam Life Science Ltd (SLS) secures exclusive License for unique Liver Cell Line from Premier U.S. Research Organization, Walter Reed Army Institute of Research (WRI) - Siam-Lifescience.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A breakthrough technology in the form of a unique, functional human liver cell line has the potential to become the new worldwide gold standard for preclinical drug evaluation studies. The cell line, licensed by Thailand-based human cell technology company, Siam Life Science Ltd. (SLS), was developed in Thailand at the Armed Forces Research Institute of the Medical Sciences (AFRIMS). The AFRIMS is a foreign activity of the Walter Reed Army Institute of Research (WRAIR) which is the largest and most diverse biomedical research laboratory in the United States’ Department of Defense.

Developed under a Cooperative Research and Development Agreement (CRADA), this unique human liver cell line is licensed to SLS on a worldwide basis and includes the exclusive right for SLS to sublicense the technology for certain uses to external partners. Known as HC-04, it is an immortalized cell line that can continue to grow and divide indefinitely in vitro. Unlike other immortalized liver cell lines, HC-04 was developed from normal human liver tissue without genetically manipulating the liver cells. More importantly, HC-04 has been shown to retain most of its normal liver cell functions and is therefore ideally suited for preclinical drug evaluation and drug safety studies. SLS was granted exclusive rights to these uses under the license with the Army.

The HC-04 cell line can be used for research and drug development for treating Malaria and Hepatitis. Use of HC-04 in malaria drug development is especially attractive because the cell line can support the in vitro development of two major Malaria parasites, Plasmodium falciparum and Plasmodium vivax. HC-04 cells may also be used in the development of bio-artificial liver devices and SLS was granted license rights to these uses as well.

SLS intends to make the HC-04 cell line available to the global pharmaceutical industry for toxicological and pharmacological testing as well as drug development. “There is a worldwide shortage of functional human liver cell test systems for preclinical drug evaluation studies,” said Walter Beerheide, PhD, CEO of SLS. “Most human liver cell lines currently on the market are not suitable for such studies, because they lose much of their normal liver cell characteristics. Our cell line addresses this and provides a reliable, stable and reproducible model for drug toxicology studies. It has the potential to become a gold standard among pharmacological and toxicological test systems for the pharma and life science industry. This latest development will contribute towards our goal of becoming an internationally-competitive human cell technology company.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: DN Venture Partners

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Walter Reed Army Institute of Research and Siam Life Science Ltd Develop New Gold Standard for Pharmacological and Toxicological Test Systems

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Marvin Ng - DN-Venture.com 
+65 9684 2133 pr[.]siam-lifescience.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any DN Venture Partners securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From DN Venture Partners / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)